REDUCER-I: An Observational Study of the Neovasc Reducer™ System

Active, not recruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

November 30, 2023

Study Completion Date

December 31, 2028

Conditions
Angina PectorisAngina Pectoris, StableChronic Stable Angina
Interventions
DEVICE

Reducer System

An aid in the management of chronic refractory angina pectoris

Trial Locations (25)

1205

Hopitaux Universitaires Geneve (HUG), Geneva

1708

HFR Fribourg/University of Fribourg, Fribourg

2020

ZNA Middelheim Hospital, Antwerp

3600

Zienkenhuis Oost-Limburg, Genk

6900

Istituto Cardiocentro Ticino, Lugano

8010

University of Graz, Graz

20132

San Raffaele Hospital, Milan

20246

University Heart Center Hamburg, Hamburg

24068

Bolognini General Hospital, Seriate

28040

Hospital Clinico San Carlos, Madrid

35392

University Giessen, Giessen

45138

Contilia Heart and Vascular Centre, Elisabeth Krankenhaus Essen, Klinik fϋr Kardiologie und Angiologie, Essen

61231

Kerckhoff Klinik, Bad Nauheim

79106

University Heart Center Freiburg - Bad Krozingen, Freiburg im Breisgau

Unknown

University Hospital of Brest, Brest

Institut Coeur Poumon, Lille

01307

Dresden University, Dresden

3435CM

St. Antonius Ziekenhuis, Nieuwegein

3584 CX

UMC Utrecht, Utrecht

CH-4031

University Hospital Basel, Basel

BD9 6RJ

Bradford Royal Infirmary, Bradford

EH16 4SA

Royal Infirmary of Edinburgh, Edinburgh

SE1 7EH

St. Thomas Hospital, London

SE5 9RS

King's College Hospital, London

SW3 6NP

Royal Brompton Hospital, London

All Listed Sponsors
lead

Shockwave Medical, Inc.

INDUSTRY

NCT02710435 - REDUCER-I: An Observational Study of the Neovasc Reducer™ System | Biotech Hunter | Biotech Hunter